Theralase Technologies Inc. V.TLT

Looking for help w/numbers for burn rate, cash on hand, et.

[BuenaSuertaAtod]

I've read here that $390K/mo was burn rate for 2020. $390 x 12mo = $4,680K for the year.

I've also read here that $7,800k cash on hand remains at YE 2020. $7,800K + $4,680K = $11,480K

In Jan 2020 units were issued that raised total gross funds of at least $17,250,000. Net would be quite a bit less than that. Just the same, if $4,680 was what they burned through in 2020 there ought to be more cash left over from that PP than $7,800K shouldn't there?

Where have my numbers gone wrong?

[99942Apophis]

Welcome aboard BuenaSuertaAtod that PP which raised 17.2M was done in August 22 2019. You really need to do more research in this company, your facts seem to be incorrect.

[Biggainer]

Here is the breakdown of their burn rate. As of 06/30/2019 cash and cash equivalents of $ 1,134,725 On 08/22/2019 - PP of $17,250,000 minus 6% ($ 1,035,000) for finders fee = $ 16,215,000 As of 09/30/2019 cash and cash equivalents of $ 14,975,634 ( - $ 2,374,091) per quarter  As of 12/31/2019 cash and cash equivalents of $ 12,548,550 ( - $ 2,427,085) As of 03/31/2020 cash and

[Rumpl3StiltSkin]

I think they'll be ok once they achieve GLP for Rutherrin, which is what they need to focus on this year. Then maybe they get some good Covid vaccine/therapy news by EoY. Next year will take care of itself $$$ moneywise if NMIBC remains on track. Remember, TLT now has it's own ACT research center ala LKSKI. Money won't be a problem if the data is there. Which it appears is the case.

[CancerSlayer]

  Yep....have to keep the right perspective.  Future funding will no doubt be less painful, whether it be through grants or a less dilutive PP.  But ultimately, it's important to keep focused on the endgame....developing the ability to offer another effective bladder-preserving option that entails fewer treatments, minimizes morbidity & significantly extends one's

[enriquesuave]

Nice points Cancer Slayer.  The N-803 + BCG combo trial is showing about 42% CR at 12 months. 72% of patients achieved a CR at one point and 59% of these maintained a CR rate which equates to 42% overall.  It's hard to know how much is attributable to BCG and how much to N-803.  Still 15-20 instillations.  Very good chance we can beat those numbers, but even if we match we

[CancerSlayer]

Enriquesuave wrote:   "Nice points Cancer Slayer.  The N-803 + BCG combo trial is showing about 42% CR at 12 months. 72% of patients achieved a CR at one point and 59% of these maintained a CR rate which equates to 42% overall.  It's hard to know how much is attributable to BCG and how much to N-803.  Still 15-20 instillations.  Very good chance we can beat

[BuenaSuertaAtod]

Many thanks for the excellent info Biggainer! I like that most recent 6 quarters show a clear trend downward in burn rate from well over $2 million per quarter to less than $1 million per quarter. You say that you expect "the burn rate will be much higher as they go through phase II". Is that the nature of a phase II in general? Is that good (because they're on to phase II), bad

[Rumpl3StiltSkin]

At the current burn rate trend, shown above, it appears that TLT is trying hard to get Phase 2 across the finish line. I think max people treated will be ~ 50. then we will see a strategic halt in phase 2 as we await FDA BTD and AA. My guess is TLT will get CR %s up into the 80s.  I do think we will see an increase in burn rate, but it might not go up dramatically as we have seen the trend

[BuenaSuertaAtod]

Rumpl3StiltSkin, you ended your comment with "cash Infusions from Canadian Govt. and or LKSKI. :-)". I second your ":-)". I'd be very interested to learn more about the prospects of such cash infusions. I know that grants and such are at times made to publicly traded medical companies that show promise of serving the greater good. Why not TLT?

[Rumpl3StiltSkin]

Yes, Me too. At this point that $$$$ is speculative. Who knows if the Canadian Govt. will see the value in developing a Cad Vaccine/Treatment for Covid X? Or what, if any, strings might be attatched to LKSKI money? Li Ka Shing has been known to do things altruistically, as well as shrewd investments. By end of year I'd think there would be some news out from the Covid research team. IF that

[Pandora]

An interesting overview of the fight against Covid in Canada. Particularly the way they dropped the ball re long term care facilities (and seem to still have not picked it up -- every day they announce "sadly 'xx' people have passed away from covid" but they do not say whether they are long term care anymore. I think he makes a good summary. https://www.todayville.com/edmonton

[tdon1229]

A vaccine expert speaks out regarding misguided approaches to dealing with Covid: https://thehighwire.com/videos/a-coming-covid-catastrophe/

[fredgoodwinson]

We seem to be in a better place than is suggested by the market following recent positive announcements though it may take the next Quarterly to confirm what many of us were hoping and are now at least to a degree beginning to anticipate from results for those in Phase II who have received optimal treatment ab initio. There have been a few wobbles - maybe only to be expected with a new drug

[Biggainer]

The reason why the burn rate has gone down the last few quarters is that covid has shut down treatment for patients, That is why we'll have a better idea on how much they're spending on treatment the next quarter and the quarter after that. When they begin to treat all 25 patients their burn rate will be much higher as logic would suggest. As for being good or bad is dependent on the phase

[tdon1229]

  As I've noted previously, US clinical trial sites usually are funded in advance.  Fees are paid to the FDA and funds are provided to the trial sites to cover the costs for investigators for the duration of the trials.  Opening of the six US sites in the first quarter of 2021 will be shown by a sharp drawdown of funds available in the corresponding quarter.  The next